News
Business
Economy
Politics
Technology
Environment
Search
Saturday, November 16, 2024
No menu items!
News
Business
Economy
Politics
Technology
Environment
Search
Home
Eli Lilly says U.S. FDA rejects accelerated approval for Alzheimer’s drug
FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant
FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant
FILE PHOTO: An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar
- Advertisment -
Most Read
How Trump’s Pentagon pick Hegseth fell out of love with the U.S. military
November 15, 2024
Palantir shares rally to fresh record on plans for move to Nasdaq
November 15, 2024
EV companies, battery makers urge Trump not to kill vehicle tax credits
November 15, 2024
Musk expands lawsuit against OpenAI, adding Microsoft and antitrust claims
November 15, 2024
We use cookies to ensure that we give you the best experience on our website.
Ok